Evidence map›Paper›PMID 29169817›Full record

ArticleMedecine et maladies infectieuses2018

The French Infectious Diseases Society's readiness and response to epidemic or biological risk-the current situation following the Middle East respiratory syndrome coronavirus and Ebola virus disease alerts.

H Coignard-Biehler, C Rapp, J M Chapplain, B Hoen, D Che, P Berthelot, F Cazenave-Roblot, C Rabaud, P Brouqui, C Leport and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medecine et maladies infectieuses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

H Coignard-BiehlerUnité de coordination opérationnelle du risque épidémique et biologique, AP-HP, 75001 Paris, France; Service des maladies infectieuses et tropicales, hôpital Necker-Enfants malades, 75015 Paris, France; Samu 75, hôpital Necker-Enfants malades, 75015 Paris, France. Electronic address: helene.coignard-biehler@chu-lyon.fr.
C RappCMETE, 10, rue du Colonel-Driant, 75001 Paris, France; Hôpital d'instruction des armées Bégin, 69, avenue de Paris, 94160 Saint-Mandé cedex, France.
J M ChapplainUnité de coordination opérationnelle du risque épidémique et biologique, AP-HP, 75001 Paris, France; Service des maladies infectieuses et tropicales, hôpital Pontchaillou, 35000 Rennes, France.
B HoenInserm CIC 14-24, faculté de médecine Hyacinthe-Bastaraud, université des Antilles, centre hospitalier universitaire, 97110 Pointe-à-Pitre, Guadeloupe.
D CheSanté publique France, 94410 Saint-Maurice, France.
P BerthelotUnité d'hygiène interhospitalière, service des maladies infectieuses et laboratoire des agents infectieux et hygiène, CHU de Saint-Etienne, 42270 Saint-Priest-en-Jarez, France.
F Cazenave-RoblotService des maladies infectieuses et tropicales, CHU de Poitiers, 86021 Poitiers, France.
C RabaudService des maladies infectieuses et tropicales, CHRU de Nancy, 54000 Nancy, France.
P BrouquiService des maladies infectieuses et tropicales, hôpital Nord, 13000 Marseille, France.
C LeportUnité de coordination opérationnelle du risque épidémique et biologique, AP-HP, 75001 Paris, France; UMR 1137, Inserm, université Paris Diderot, 75018 Paris, France.
SPILF-COREB Emergences group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextIn 2012, the French Infectious Diseases Society (French acronym SPILF) initiated the "Coordination of epidemic and biological risk" (SPILF-COREB - Emergences [SCE]) group to support the readiness and response of healthcare workers (HCWs) to new alerts.

objectiveTo present the SCE group, its functioning, and the main support it provided for frontline HCWs.

methodsA multidisciplinary group of heads of infectious disease departments from reference hospitals was created to build a network of clinical expertise for care, training, and research in the field of epidemic and biological risk (EBR). The network developed a set of standardized operational procedures (SOPs) to guide interventions to manage EBR-suspect patients.

resultsA working group created the SOP aimed at frontline HCWs taking care of patients. Priority was given to the development of a generic procedure, which was then adapted according to the current alert. Five key steps were identified and hierarchized: detecting, protecting, caring for, alerting, and referring the EBR patient. The interaction between clinicians and those responsible for the protection of the community was crucial. The SOPs validated by the SPILF and its affiliates were disseminated to a wide range of key stakeholders through various media including workshops and the SPILF's website.

conclusionSPILF can easily adapt and timely mobilize the EBR expertise in case of an alert. The present work suggests that sharing and discussing this experience, initiated at the European level, can generate a new collective expertise and needs to be further developed and strengthened.

Indexed as

Middle East Respiratory Syndrome CoronavirusCoronavirus InfectionsEpidemicsFranceHemorrhagic Fever, EbolaHumansRiskRisk FactorsSocieties, MedicalClinical networkEmerging infectious diseasesEpidemic and biological riskMaladies infectieuses émergentesProcédures opérationnelles standardiséesRéseau cliniqueRisque épidémique et biologiqueStandardized operating procedures

Identifiers

PMID29169817
PMCPMC7125712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.